Blog

The platform is the first to combat non-adherence in clinical trials, a cause of 30% of failures, through advanced precision dosing technology and real-time behavioral support and engagement solutions

Validose appoints CEO as it prepares launch of multi-therapeutic category platform focused on improving clinical trial adherence.